» Authors » Eduard E Zijlstra

Eduard E Zijlstra

Explore the profile of Eduard E Zijlstra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 1739
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fahal A, Ahmed E, Bakhiet S, Bakhiet O, Fahal L, Mohamed A, et al.
Lancet Infect Dis . 2024 Aug; 24(11):1254-1265. PMID: 39098321
Background: Eumycetoma is an implantation mycosis characterised by a large subcutaneous mass in the extremities commonly caused by the fungus Madurella mycetomatis. Despite the long duration of treatment, commonly a...
2.
Younis B, Musa A, Monnerat S, Abdelrahim Saeed M, Awad Gasim Khalil E, Elbashir Ahmed A, et al.
PLoS Negl Trop Dis . 2023 Nov; 17(11):e0011780. PMID: 37988402
Background: Treatment for post-kala-azar dermal leishmaniasis (PKDL) in Sudan is currently recommended only for patients with persistent or severe disease, mainly because of the limitations of current therapies, namely toxicity...
3.
Nyuykonge B, Siddig E, Nyaoke B, Zijlstra E, Verbon A, Bakhiet S, et al.
Mycoses . 2023 Oct; 67(1):e13664. PMID: 37872649
Introduction: (1,3)-β-D-glucan is a panfungal biomarker secreted by many fungi, including Madurella mycetomatis, the main causative agent of eumycetoma. Previously we demonstrated that (1,3)-β-D-glucan was present in serum of patients...
4.
Siddig E, Nyuykonge B, Mhmoud N, Abdallah O, Bahar M, Ahmed E, et al.
Mycoses . 2022 Dec; 66(5):420-429. PMID: 36583225
Objectives: Mycetoma is a neglected tropical implantation disease caused by 70 different infectious agents. Identifying the causative organism to the species level is essential for appropriate patient management. Ultrasound, histopathology,...
5.
Nyuykonge B, Siddig E, Mhmoud N, Nyaoke B, Zijlstra E, Verbon A, et al.
Mycoses . 2022 Aug; 65(12):1170-1178. PMID: 36005544
Background: Eumycetoma is a neglected tropical disease. It is a chronic inflammatory subcutaneous infection characterised by painless swellings which produce grains. It is currently treated with a combination of itraconazole...
6.
Zijlstra E
Front Cell Infect Microbiol . 2021 Dec; 11:707619. PMID: 34858865
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the...
7.
Zijlstra E, Kumar A, Sharma A, Rijal S, Mondal D, Routray S
Parasit Vectors . 2020 Apr; 13(1):159. PMID: 32228668
The 5th Post-Kala-Azar Dermal Leishmaniasis (PKDL) Consortium meeting brought together PKDL experts from all endemic areas to review and discuss existing and new data on PKDL. This report summarizes the...
8.
Zijlstra E, Liberton N, Musa A, Te Slaa S, Wolff J
Am J Trop Med Hyg . 2020 Jan; 102(2):286-288. PMID: 31889505
Post-kala-azar dermal leishmaniasis may occur after successful treatment of visceral leishmaniasis and is characterized by macules, papules, or nodules in the skin, with varying size. The response to antileishmanial therapy...
9.
Zijlstra E, van Hellemond J, Moes A, de Boer C, Boeschoten S, van Blijswijk C, et al.
Am J Trop Med Hyg . 2019 Dec; 102(2):451-457. PMID: 31837130
Nontraumatic myelopathy causes severe morbidity and is not uncommon in Africa. Clinically, patients often present with paraplegia, and extrinsic cord compression and transverse myelitis are most common causes. Data on...
10.
Hay R, Denning D, Bonifaz A, Queiroz-Telles F, Beer K, Bustamante B, et al.
Trop Med Infect Dis . 2019 Sep; 4(4). PMID: 31554262
The diagnosis of fungal Neglected Tropical Diseases (NTD) is primarily based on initial visual recognition of a suspected case followed by confirmatory laboratory testing, which is often limited to specialized...